Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 8, December

Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)]

Volume:8   Issue: 8
Pp: 817-817
Gregoire Pierre Prevost
DOI: 10.2174/187152008786847774
Published on: 01 March, 2012

Cell Cycle Control by the CDC25 Phosphatases

Volume:8   Issue: 8
Pp: 818-824
Bernadette Aressy and Bernard Ducommun
DOI: 10.2174/187152008786847756
Published on: 01 March, 2012

CDC25A: A Rebel Within the CDC25 Phosphatases Family?

Volume:8   Issue: 8
Pp: 825-831
Anne Fernandez-Vidal, Anne Mazars and Stephane Manenti
DOI: 10.2174/187152008786847684
Published on: 01 March, 2012

In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets

Volume:8   Issue: 8
Pp: 832-836
Hiroaki Kiyokawa and Dipankar Ray
DOI: 10.2174/187152008786847693
Published on: 01 March, 2012

Is Cdc25 a Druggable Target?

Volume:8   Issue: 8
Pp: 837-842
John S. Lazo and Peter Wipf
DOI: 10.2174/187152008786847738
Published on: 01 March, 2012

Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective

Volume:8   Issue: 8
Pp: 843-856
Antonio Lavecchia, Antonio Coluccia, Carmen Di Giovanni and Ettore Novellino
DOI: 10.2174/187152008786847783
Published on: 01 March, 2012

CDC25 Inhibitors as Anticancer Agents Are Moving Forward

Volume:8   Issue: 8
Pp: 857-862
M.-C. Brezak, P. G. Kasprzyk, M.-O. Galcera, O. Lavergne and G. P. Prevost
DOI: 10.2174/187152008786847701
Published on: 01 March, 2012

Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies

Volume:8   Issue: 8
Pp: 863-871
Z. Wang, S. Kar and B. I. Carr
DOI: 10.2174/187152008786847675
Published on: 01 March, 2012

Proliferation of Breast Cancer Cells: Regulation, Mediators, Targets for Therapy

Volume:8   Issue: 8
Pp: 872-885
J. Mester and G. Redeuilh
DOI: 10.2174/187152008786847747
Published on: 01 March, 2012

Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy

Volume:8   Issue: 8
Pp: 886-903
Chantal Barthomeuf, Marie-Lise Bourguet-Kondracki and Jean-Michel Kornprobst
DOI: 10.2174/187152008786847729
Published on: 01 March, 2012

Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative

Volume:8   Issue: 8
Pp: 904-909
Alfonso Quintas-Cardama, Srdan Verstovsek, Emil Freireich, Hagop Kantarjian, Yi Wen Chen and Ralph Zingaro
DOI: 10.2174/187152008786847666
Published on: 01 March, 2012

Analogues of Marine Pyrroloiminoquinone Alkaloids: Synthesis and Antitumor Properties

Volume:8   Issue: 8
Pp: 910-916
Evelyne Delfourne
DOI: 10.2174/187152008786847710
Published on: 01 March, 2012

Autotaxin Inhibition: Challenges and Progress Toward Novel Anti-Cancer Agents

Volume:8   Issue: 8
Pp: 917-923
Abby L. Parrill and Daniel L. Baker
DOI: 10.2174/187152008786847765
Published on: 01 March, 2012